| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b03426a240f658243640eabe17153fc3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c365acb74f014eb22f745a2cbc766f1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_399d426408ce1e752b8d3915985741a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46e67a55db7bbfd2f0e7247516db0eb7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_562f8e7e5ab22970cd80636312856ce3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2008-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e834f9a0a6fa9e45b84b1c6545037bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ca36cabef55946b04ba08fb929ff93e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0d518cf13790032d7964ecb5cfdee85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9066fb5cb66ff09f097644f9cfe86d82 |
| publicationDate |
2008-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008152764-A1 |
| titleOfInvention |
Pharmaceutical composition |
| abstract |
Disclosed is a pharmaceutical composition containing a highly stable 2-nitroimidazole derivative which exhibits high solubility in an aqueous carrier. Specifically disclosed is a pharmaceutical composition characterized by containing 1-(1-hydroxymethyl-2,3- dihydroxypropyl)oxymethyl-2-nitroimidazole and 0.001-1 part by mass of creatinine per 1 part by mass of the compound. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015091766-A |
| priorityDate |
2007-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |